Advantage of postoperative oral administration of tegafur (FT) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC)

• TANAKA F.

収録刊行物

• Proc. ASCO

  Proc. ASCO 15 393-, 1996

詳細情報

• CRID: 1572824499507803648
• NII論文ID: 10008090155
• データソース種別:
  • CiNii Articles